Diagnostic anti-[ebola virus (EV)] antibodies pairs for testing in ELISA, Lateral flow immunoassay (LFIA) and other immunoassays

Ebola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus. The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename "Ervebo") for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.Genemedi produces core diagnostic ingredients-validated antibodies pairs Mouse anti-ebola virus (EV) monoclonal antibodies for rapid test kit of ebola virus (EV) to evaluate the related human infectious disease.The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in diagnostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-EV-1Ab-1mg	1mg	1953
GMP-EV-1Ab-10mg	10mg	13671
GMP-EV-1Ab-100mg	100mg	95697
GMP-EV-1Ab-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Antigen & Antibody Name	Mouse anti-ebola virus (EV) monoclonal antibodies
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays in[ebola virus (EV)] level test in human infectious disease diagnositcs.
Tag	mFc
Products description	Ebola Virus Disease (EVD) is a rare and deadly disease in people and nonhuman primates. The viruses that cause EVD are located mainly in sub-Saharan Africa. People can get EVD through direct contact with an infected animal (bat or nonhuman primate) or a sick or dead person infected with Ebola virus. The U.S. Food and Drug Administration (FDA) has approved the Ebola vaccine rVSV-ZEBOV (tradename "Ervebo") for the prevention of EVD. The rVSV-ZEBOV vaccine has been found to be safe and protective against only the Zaire ebolavirus species of ebolavirus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.